Maze Therapeutics Inc (MAZE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Sales | 167,500 | 0 | 0 |
| Gross Profit | 167,500 | N/A | N/A |
| Operating Expenses | 109,914 | 98,551 | 111,026 |
| Operating Income | 57,586 | -98,551 | -111,026 |
| Other Income | -4,183 | -1,864 | -3,914 |
| Pre-tax Income | 53,403 | -100,415 | -114,940 |
| Income Tax | 1,172 | N/A | N/A |
| Net Income Continuous | 52,231 | -100,415 | -114,940 |
| Net Income | $52,231 | $-100,415 | $-114,940 |
| EPS Basic Total Ops | 1.42 | -43.89 | -57.21 |
| EPS Basic Continuous Ops | 21.80 | -43.89 | -57.21 |
| EPS Diluted Total Ops | 1.25 | -43.89 | -57.21 |
| EPS Diluted Continuous Ops | 19.13 | -43.89 | -57.21 |
| EPS Diluted Before Non-Recurring Items | 1.25 | N/A | N/A |
| EBITDA(a) | $60,883 | $-94,462 | $-107,206 |